These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6043735)

  • 21. Antiviral, antimetabolic and antineoplastic activities of 2'- or 3'-amino or -azido-substituted deoxyribonucleosides.
    De Clercq E; Balzarini J; Descamps J; Eckstein F
    Biochem Pharmacol; 1980 Jun; 29(12):1849-51. PubMed ID: 7406907
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
    Wang JJ; Chervinsky DS; Rosen JM
    Cancer Res; 1972 Mar; 32(3):511-5. PubMed ID: 5061305
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of drugs inhibiting different steps in the synthesis of DNA.
    Grindey GB; Nichol CA
    Cancer Res; 1972 Mar; 32(3):527-31. PubMed ID: 4258632
    [No Abstract]   [Full Text] [Related]  

  • 24. Antitumor activity and mode of action of 2-thio-6-azauridine (NSC-146268) on L1210 leukemia.
    Li LH; Neil GL; Moxley TE; Olin EJ
    Cancer Chemother Rep; 1974; 58(3):345-52. PubMed ID: 4858297
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
    Balzarini J; De Clercq E
    Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical studies of a new antitumor agent, O2,2'-cyclocytidine.
    Ho DH
    Biochem Pharmacol; 1974 Apr; 23(8):1235-44. PubMed ID: 4824772
    [No Abstract]   [Full Text] [Related]  

  • 27. Determinants of response to antimetabolites and their modulation by normal purine and pyrimidine metabolites.
    Rustum YM; Danhauser L; Luccioni C; Au JL
    Cancer Treat Rep; 1981; 65 Suppl 3():73-82. PubMed ID: 7049369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some determinants of camptothecin responsiveness in leukemia L1210 cells.
    Kessel D
    Cancer Res; 1971 Dec; 31(12):1883-7. PubMed ID: 5120286
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of antimetabolites on kinetic behavior of proliferating cultured L1210 leukemia cells.
    Wilkoff LJ; Wilcox WS; Burdeshaw JA; Dixon GJ; Dulmadge EA
    J Natl Cancer Inst; 1967 Nov; 39(5):965-75. PubMed ID: 6071005
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
    Mizuno NS; Humphrey EW
    Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic effects of cyclic 9- -D-arabinofuranosyladenine 3',5'-monophosphate in L1210 cells.
    Hughes RG; Kimball AP
    Cancer Res; 1972 Sep; 32(9):1791-4. PubMed ID: 4345037
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210.
    Young RC; DeVita VT
    Cancer Res; 1970 Jun; 30(6):1789-94. PubMed ID: 5457940
    [No Abstract]   [Full Text] [Related]  

  • 33. Flow microfluorometric analysis of the cell cycle phase cytotoxicity of ARA-C.
    Hromas RA; Markel DE; Scholes VE
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):365-8. PubMed ID: 7444164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resting cells in L1210 and JB-1 ascites tumors with special emphasis on recycling.
    Hartmann NR; Dombernowsky P; Bichel P
    Cancer Treat Rep; 1976 Dec; 60(12):1861-70. PubMed ID: 1026340
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell-kill kinetics of several S-phase-specific drugs.
    Bhuyan BK; Fraser TJ; Gray LG; Kuentzel SL; Neil GL
    Cancer Res; 1973 Apr; 33(4):888-94. PubMed ID: 4735241
    [No Abstract]   [Full Text] [Related]  

  • 36. Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.
    Bhuyan BK; Fraser TJ; Day KJ
    Cancer Res; 1977 Apr; 37(4):1057-63. PubMed ID: 139202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of the inhibition of DNA biosynthesis by 4,4'-diacetyldiphenylurea-bis(guanylhydrazone) in leukemia L1210 cells.
    Dave C; Ehrke J; Mihich E
    Cancer Res; 1973 Sep; 33(9):2129-34. PubMed ID: 4737638
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of N-nitroso-N'-methylurea on the cellular kinetics in tumors].
    Ostrovskaia LA; Frankfurt OS
    Vopr Onkol; 1977; 23(2):88-93. PubMed ID: 857417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA.
    Roberts D; Wodinsky I
    Cancer Res; 1968 Oct; 28(10):1955-62. PubMed ID: 5696929
    [No Abstract]   [Full Text] [Related]  

  • 40. Specific metabolic changes in DNA-treated L1210 leukemia cells.
    Glick JL; Sahler C
    Cancer Res; 1967 Dec; 27(12):2342-9. PubMed ID: 4230120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.